Unlike TNBC, ER+ breast cancers did not display age-stratified immune responses, apart from tumor necrosis factor alpha (TNFα) signaling, which was enriched in the younger cohort (Fig. 1d, Supplementary Table 3). The gene discussed is TNF; the disease is breast carcinoma.